As of the latest SEC filings, CRESCENT BIOPHARMA, INC. (CBIO) is held by 29 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $12,837,801.02 in market value, representing a significant portion of its portfolio.
Funds holding CRESCENT BIOPHARMA, INC. (CBIO)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- CBIO
- CIK:
- 0001253689
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $12,837,801.02 | 698,846 | Mar 31, 2026 | May 28, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.14% | $11,599,538.47 | 518,531 | Apr 30, 2026 | Jun 26, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.01% | $7,820,283.51 | 646,839 | Feb 28, 2026 | Apr 24, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.30% | $5,616,883.30 | 251,090 | Apr 30, 2026 | Jun 26, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.13% | $5,364,482.59 | 239,807 | Apr 30, 2026 | Jun 26, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.04% | $4,060,964.05 | 221,065 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.00% | $3,538,489.11 | 292,679 | Feb 28, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.01% | $2,250,154.53 | 186,117 | Feb 28, 2026 | Apr 24, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 0.12% | $2,198,971.00 | 98,300 | Apr 30, 2026 | Jun 26, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.01% | $1,997,268.00 | 165,200 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.03% | $1,803,126.78 | 149,142 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $1,505,164.32 | 81,936 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.03% | $1,371,259.89 | 113,421 | Feb 28, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.01% | $1,263,489.63 | 104,507 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.00% | $836,567.55 | 69,195 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $483,865.98 | 40,022 | Feb 28, 2026 | Apr 24, 2026 |
|
VBINX
VANGUARD BALANCED INDEX FUND
|
MF | Vanguard | 0.00% | $231,590.59 | 12,607 | Mar 31, 2026 | May 28, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $153,530.91 | 12,699 | Feb 28, 2026 | Apr 24, 2026 |
|
PEXMX
T. Rowe Price Extended Equity Market Index Fund
|
MF | T. Rowe Price | 0.02% | $152,471.00 | 8,300 | Mar 31, 2026 | May 28, 2026 |
|
VITNX
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
|
MF | Vanguard | 0.00% | $147,070.22 | 8,006 | Mar 31, 2026 | May 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $144,789.84 | 11,976 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $121,105.53 | 10,017 | Feb 28, 2026 | Apr 24, 2026 |
|
JAFMX
Health Sciences Trust
|
MF | John Hancock | 0.05% | $109,466.83 | 5,959 | Mar 31, 2026 | May 29, 2026 |
|
-
EQ/T.Rowe Price Health Sciences Portfolio
|
ETF | Independent / Boutique | 0.05% | $81,085.18 | 4,414 | Mar 31, 2026 | May 26, 2026 |
|
USMIX
Victory Extended Market Index Fund
|
MF | Independent / Boutique | 0.01% | $50,108.80 | 2,240 | Apr 30, 2026 | Jun 25, 2026 |
Advertisement (320x50)